Synergy Laboratories has introduced a new testing platform to increase its Covid-19 diagnostic capabilities. The platform is expected to double the company’s Reverse Transcription – Polymerase Chain Reaction (RT-PCR) testing capability, with around 2,500 tests daily. It features a Roche cobas 6800 molecular testing unit that uses PCR technology in an automated scenario to offer accurate results in less time.
Netsmart has launched a new Covid-19 mobile screening solution that is expected to aid organisations in reopening safely as stay-at-home orders are relaxed in the US. Released in March, the Covid-19 Screening Solution is used by providers to access important screening questions and assessments. It can be accessed via smart phone, tablet or PC. The solution asks individuals about their travel and exposure, current health conditions, Covid-19 symptoms and previous Covid-19 testing results.
Moldex has increased the production of N95 respirator masks in a bid to meet the demand amid the Covid-19 pandemic. It has employed additional staff, added extra shifts and is operating at almost maximum capacity. Most of the Moldex N95 respirator masks were used in industrial settings, but US Food and Drug Administration (FDA) Emergency Use Authorisation (EUA) has allowed them to be used in non-surgical healthcare settings.
CNSystems has introduced a custom solution to aid the diagnostic and therapy-guiding functional hemodynamic tests that are recommended by frontline experts and global guidelines for Covid-19. This follows the announcement of international experts, who concluded that hemodynamic optimisation is an important aspect in managing the complex interaction of respiratory and cardiovascular factors. The solution, CNAP HD monitoring, is a non-invasive and easy-to-use solution that features a finger sensor to measure the parameters, suggested by experts, in real-time.